Wang L J, Robertson S, Seamark R F, Norman R J
Department of Obstetrics and Gynaecology, Queen Elizabeth Hospital and Medical School, University of Adelaide, Woodville, South Australia.
J Clin Endocrinol Metab. 1991 Apr;72(4):824-31. doi: 10.1210/jcem-72-4-824.
The effects of human interleukin-1 (IL-1) and IL-2 on human granulosa-luteal cell progesterone production were examined with or without hCG stimulation in vitro. Human granulosa-luteal cells were recovered from follicular fluid obtained from women undergoing in vitro fertilization procedures and cultured for up to 7 days before supernatant progesterone level measurement. Lymphokine-rich conditioned medium was prepared from mitogen-stimulated human peripheral blood leukocytes (HPL-CM). The influence of HPL-CM on both granulosa-luteal cell progesterone production and cell growth was inhibitory. In contrast, supernatants of the IL-2-producing cell line MLA-144 (MLA-CM) stimulated both basal progesterone secretion and cell proliferation. Human recombinant IL-2 (from 0.1-100 IU) alone did not change progesterone levels, compared to control values, after 24 h of cell culture. However, 1, 10, and 100 IU IL-2 significantly inhibited progesterone secretion from cells stimulated by 5 IU hCG (P less than 0.01). The enhanced progesterone levels stimulated by forskolin were also significantly inhibited by 10 IU IL-2 (P = 0.01). This effect was not mediated through decreased cAMP, since the forskolin-enhanced cAMP level was not influenced by IL-2, IL-1, with or without hCG, did not show any effect on progesterone production during either 24 or 48 h of cell culture. It is concluded that 1) human recombinant IL-2 significantly inhibits progesterone production stimulated by hCG in human granulosa-luteal cells; 2) IL-2 also had a marked inhibitory effect on forskolin-induced progesterone release, but did not influence the increased cAMP level stimulated by forskolin; 3) the inhibitory influence of IL-2 on progesterone synthesis may be down-stream in the signal transduction pathway from cAMP activation; and 4) HPL-CM and MLA-CM produced inhibitory and stimulatory effects, respectively, on both basal and hCG-stimulated progesterone levels as well as on granulosa-luteal cell proliferation. These activities cannot be completely attributed to IL-2, and other mediators of leukocyte origin may, therefore, exist.
在有或无hCG刺激的情况下,体外检测了人白细胞介素-1(IL-1)和IL-2对人颗粒黄体细胞孕酮生成的影响。从接受体外受精手术的女性卵泡液中获取人颗粒黄体细胞,并在测量上清液孕酮水平前培养长达7天。富含淋巴因子的条件培养基由丝裂原刺激的人外周血白细胞制备(HPL-CM)。HPL-CM对颗粒黄体细胞孕酮生成和细胞生长均有抑制作用。相反,产生IL-2的细胞系MLA-144的上清液(MLA-CM)刺激基础孕酮分泌和细胞增殖。细胞培养24小时后,与对照值相比,单独的人重组IL-2(0.1 - 100 IU)未改变孕酮水平。然而,1、10和100 IU的IL-2显著抑制5 IU hCG刺激的细胞的孕酮分泌(P小于0.01)。10 IU的IL-2也显著抑制了福司可林刺激增强的孕酮水平(P = 0.01)。此效应并非通过降低cAMP介导,因为福司可林增强的cAMP水平不受IL-2影响。IL-1无论有无hCG,在细胞培养24小时或48小时期间对孕酮生成均无任何影响。得出以下结论:1)人重组IL-2显著抑制hCG刺激的人颗粒黄体细胞孕酮生成;2)IL-2对福司可林诱导的孕酮释放也有显著抑制作用,但不影响福司可林刺激增加的cAMP水平;3)IL-2对孕酮合成的抑制作用可能在cAMP激活的信号转导途径的下游;4)HPL-CM和MLA-CM分别对基础和hCG刺激的孕酮水平以及颗粒黄体细胞增殖产生抑制和刺激作用。这些活性不能完全归因于IL-2,因此可能存在其他白细胞来源的介质。